Myeloid blood dendritic cells and monocyte-derived dendritic cells differ in their endocytosing capability

Human Immunology

Volumn 73, Issue 11, 2012, Pages 1073-1081

  Andersson, Linda I M ^a   Cirkic, Emina ^a   Hellman, Peter ^a   Eriksson, Håkan ^a  

^a MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN G; LECTIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL COUNT; CELL POPULATION; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; MYELOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; IMMUNOPHENOTYPING; LECTINS, C-TYPE; MONOCYTES; MYELOID CELLS; OVALBUMIN; PHENOTYPE; ZEOLITES;

EID: 84867857116     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.08.002     Document Type: Article

References (37)

1. Steinman R.M., Inaba K., Turley S., Pierre P., Mellman I. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol 1999, 60:562-567.
2. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
3. Cao W., Lee S.H., Lu J. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem J 2005, 385:85-93.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
5. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994, 179:1109-1118.
6. Mellman I. Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 1996, 12:575-625.
7. Swanson J.A., Watts C. Macropinocytosis. Trends Cell Biol 1995, 5:424-428.
8. Wilson N.S., Villadangos J.A. Regulation of antigen presentation and crosspresentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv Immunol 2005, 86:241-305.
9. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2006, 422:37-44.
10. Larsson K., Lindstedt M., Borrebaeck C.A. Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 2006, 117:156-166.
11. Dahm A., Eriksson H. Ultra-stable zeolites-a tool for in-cell chemistry. J Biotechnol 2004, 111:279-290.
12. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J., Hart D.N. Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
13. Osugi Y., Vuckovic S., Hart D.N. Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 2002, 100:2858-2866.
14. Lindstedt M., Johansson-Lindbom B., Borrebaeck C.A. Global reprogramming of dendritic cells in response to a concerted action of inflammatory mediators. Int Immunol 2002, 14:1203-1213.
15. Hellman P., Andersson L., Eriksson H. Ligand surface density is important for efficient capture of immunoglobulin and phosphatidylcholine coated particles by human peripheral dendritic cells. Cell Immunol 2009, 258:123-130.
16. Figdor C.G., van Kooyk Y., Adema G.J. C-Type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002, 2:77-84.
17. Burgdorf S., Lukacs-Kornek V., Kurts C. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol 2006, 176:6770-6776.
18. Piccioli D., Tavarini S., Borgogni E., Steri V., Nuti S., Sammicheli C., et al. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood 2007, 109:5371-5379.
19. Thiele L., Merkle H.P., Walter E. Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res 2003, 20:221-228.
20. Andersson L.I., Eriksson H. De-aluminated zeolite Y as a tool to study endocytosis, a delivery system revealing differences between human peripheral dendritic cells. Scand J Immunol 2007, 66:52-61.
21. Andersson L.I., Hellman P., Eriksson H. Receptor-mediated endocytosis of particles by peripheral dendritic cells. Hum Immunol 2008, 69:625-633.
22. Amigorena S. Fc gamma receptors and cross-presentation in dendritic cells. J Exp Med 2002, 195:F1-F3.
23. Larsson M., Berge J., Johansson A.G., Forsum U. Human dendritic cells handling of binding, uptake and degradation of free and IgG-immune complexed dinitrophenylated human serum albumin in vitro. Immunology 1997, 90:138-146.
24. Bergtold A., Desai D.D., Gavhane A., Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 2005, 23:503-514.
25. Miettinen H.M., Matter K., Hunziker W., Rose J.K., Mellman I. Fc receptor endocytosis is controlled by a cytoplasmic domain determinant that actively prevents coated pit localization. J Cell Biol 1992, 116:875-888.
26. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat Rev Immunol 2007, 7:9-18.
27. Boruchov A.M., Veri M.-C., Bonvini E., Ravetch J.V., Young J.W. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 2005, 115:2914-2923.
28. Kindberg G.M., Magnusson S., Berg T., Smedsrod B. Receptor-mediated endocytosis of ovalbumin by two carbohydrate-specific receptors in rat liver cells. The intracellular transport of ovalbumin to lysosomes is faster in liver endothelial cells than in parenchymal cells. Biochem J 1990, 270:197-203.
29. Dzionek A., Inagaki Y., Okawa K., Nagafune J., Röck J., Sohma Y., et al. Plasmacytoid dendritic cells: from specific surface marker to specific cellular functions. Hum Immunol 2002, 63:1133-1148.
30. Teunis B.H., Geijtenbeek T.B.H., Torensma R., Van Vliet S.J., Van Duijnhoven G.C.F., Adema G.J., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
31. Andreas Wollenberg A., Mommaas M., Oppel T., Schottdorf E.-M., Günther S., Moderer M. Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol 2002, 118:327-334.
32. Conti L., Gessani S. GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances. Immunobiology 2008, 213:859-870.
33. Jacobs B., Wuttke M., Papewalis C., Seissler J., Schott M. Dendritic cell subtypes and in vitro generation of dendritic cells. Horm Metab Res 2008, 40:99-107.
34. Jefford M., Schnurr M., Toy T., Masterman K.A., Shin A., Beecroft T., et al. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 2003, 102:1753-1763.
35. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005, 2005(5):296-306.
36. Lesterhuis W.J., Aarntzen E.H., De Vries I.J., Schuurhuis D.H., Figdor C.G., Adema G.J., et al. Dendritic cell vaccines in melanoma: from promise to proof?. Crit Rev Oncol Hematol 2008, 66:118-134.
37. 't'Hart B.A., van Kooyk Y. Yin-Yang regulation of autoimmunity by DCs. Trends Immunol 2004, 25:353-359.